Stocks and InvestingStocks and Investing
Fri, January 21, 2022
Thu, January 20, 2022
Wed, January 19, 2022
Tue, January 18, 2022

Matthew Harrison Maintained (BNTX) at Hold with Decreased Target to $284 on, Jan 18th, 2022


Published on 2024-10-27 19:18:44 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "BioNTech SE" (BNTX) at Hold with Decreased Target from $294 to $284 on, Jan 18th, 2022.

Matthew has made no other calls on BNTX in the last 4 months.



There are 4 other peers that have a rating on BNTX. Out of the 4 peers that are also analyzing BNTX, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold and Held Target at $225 on, Tuesday, November 9th, 2021
  • Akash Tewari of "Jefferies" Initiated at Hold and Held Target at $230 on, Thursday, October 7th, 2021
  • Daina Graybosch of "SVB Leerink" Maintained at Hold with Decreased Target to $268 on, Tuesday, October 5th, 2021


This is the rating of the analyst that currently disagrees with Matthew


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $366 on, Tuesday, December 21st, 2021